BioIntelliSense

Denver, CO · Founded 2019 · Privately Held (backing)

Developer of a remote patient monitoring device designed to enhance healthcare delivery. BioIntelliSense is based in Denver, CO and was founded in 2019. Its last reported valuation was $1.2 billion in Dec 2022. It has raised $319 million across 4 recorded rounds; the latest was a $58.3 million later-stage round in Dec 2025.

Last reported valuation
$1.2B
Oct 2026
Priced at
—
Total raised
$318.6M
Last round
Later Stage VC
Dec 2025

Who backs BioIntelliSense?

18 investors
InvestorType
Chimera CapitalAsset manager
TLG Capital ManagementPE / buyout
Mary Tolan—
Confluent—
Dexcom Ventures—
Fresenius Medical Care—
Fresenius Medical Care Ventures—
James Murren—
Jonathan Weiner—
Pendrell—
+ 8 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

BioIntelliSense investors

18 investors are on record for BioIntelliSense, including Chimera Capital, TLG Capital Management, Mary Tolan and Confluent. The later-stage round in Dec 2025 drew 14 investors.

Free account
More of BioIntelliSense with a free account
  • ·The complete investor list: 18 names
  • ·Watch BioIntelliSense: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 18 firms already write checks for companies like BioIntelliSense. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View